A Bayesian Measure of the Probability of False Discovery in Genetic Epidemiology Studies

In light of the vast amounts of genomic data that are now being generated, we propose a new measure, the Bayesian false-discovery probability (BFDP), for assessing the noteworthiness of an observed association. BFDP shares the ease of calculation of the recently proposed false-positive report probab...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of human genetics Vol. 81; no. 2; pp. 208 - 227
Main Author Wakefield, Jon
Format Journal Article
LanguageEnglish
Published Chicago, IL Elsevier Inc 01.08.2007
University of Chicago Press
Cell Press
American Society of Human Genetics
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In light of the vast amounts of genomic data that are now being generated, we propose a new measure, the Bayesian false-discovery probability (BFDP), for assessing the noteworthiness of an observed association. BFDP shares the ease of calculation of the recently proposed false-positive report probability (FPRP) but uses more information, has a noteworthy threshold defined naturally in terms of the costs of false discovery and nondiscovery, and has a sound methodological foundation. In addition, in a multiple-testing situation, it is straightforward to estimate the expected numbers of false discoveries and false nondiscoveries. We provide an in-depth discussion of FPRP, including a comparison with the q value, and examine the empirical behavior of these measures, along with BFDP, via simulation. Finally, we use BFDP to assess the association between 131 single-nucleotide polymorphisms and lung cancer in a case-control study.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
This work was performed while on sabbatical at the International Agency for Research on Cancer, Lyon, France.
ISSN:0002-9297
1537-6605
DOI:10.1086/519024